Tata Elxsi has announced the launch of a dedicated Offshore Development Center (ODC) for Terumo Corporation, reinforcing a strategic collaboration focused on advancing cardiac and vascular medical technologies. The newly inaugurated center is designed to enhance product development capabilities, strengthen engineering excellence, and provide end-to-end lifecycle support for global markets.
The Offshore Development Center brings together specialized, cross-functional teams to support the design, development, validation, and regulatory processes associated with Terumo’s cardiovascular solutions. By combining domain expertise with advanced digital tools, the center aims to accelerate innovation cycles and improve responsiveness to regional market needs.
A key aspect of the collaboration is the integration of advanced technologies such as artificial intelligence and data-driven engineering into the product development process. These capabilities will enable faster iteration, improved design accuracy, and more efficient adaptation of medical devices for different geographies. The initiative also addresses the growing demand for patient-focused healthcare solutions that balance performance, affordability, and differentiation.
Through this partnership, Tata Elxsi will contribute its experience in design-led engineering, verification, compliance, and localization to support Terumo’s global product roadmap. The collaboration is expected to enhance the reliability and performance of cardiovascular devices while ensuring adherence to stringent international quality and safety standards.
Fumihisa Hirose, President of the Cardiac & Vascular Company at Terumo Corporation, stated that the new development center will play a critical role in strengthening the company’s innovation capabilities. He noted that the collaboration will support faster delivery of high-quality medical technologies across global markets, while maintaining strong compliance and safety benchmarks.
Sreevatsa Sahasranaman, Senior Vice President and Head of Healthcare & Life Sciences at Tata Elxsi, emphasized that the initiative represents a long-term partnership model built on shared expertise and innovation goals. He highlighted the company’s focus on combining engineering, design, and regulatory capabilities with emerging technologies to drive efficiency and support the development of next-generation medical solutions.
Headquartered in Bengaluru, Tata Elxsi is a global provider of design and technology services across multiple industries, including healthcare, automotive, broadcast, and communications. Its Healthcare & Life Sciences division is ISO 13485 certified and works closely with leading global medical device and pharmaceutical companies. The establishment of the Offshore Development Center marks a significant step in expanding global collaboration in medical technology, with a focus on improving patient outcomes and enabling broader access to advanced cardiovascular care.
